Omega-3 Supplementation to Both Parent and Adolescent

Sponsor
Joint Child Health Project, Mauritius (Other)
Overall Status
Recruiting
CT.gov ID
NCT05893550
Collaborator
University of Pennsylvania (Other)
800
1
4
64.9
12.3

Study Details

Study Description

Brief Summary

The overarching, long-term goals are to develop a non-invasive biological approach to prevention of youth aggression, and ultimately adult violence.

The specific aims of this 2 x 2 randomized, double-blind, stratified, placebo-controlled trial of omega-3 supplementation to adolescents and caregivers are: (1) to investigate whether a nutritional intervention to adolescents and their parents can reduce externalizing behavior problems; (2) to examine the impact of a dual nutritional intervention to both parents and adolescents on adolescent externalizing behavior problems; (3) to identify mechanisms of action by which omega-3 supplementation impacts externalizing behavior in adolescents. It is expected that omega-3 supplementation will reduce adolescent behavior problems, and that dual supplementation to both the caregiver and adolescent will result in exponential improvements in adolescent behavior. A secondary prediction is that improvements in neurocognitive functioning will partially account for any behavioral improvements observed. Effects on scholastic ability are also explored.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Smartfish Omega
  • Dietary Supplement: Smartfish Fruit Juice Only
Phase 3

Detailed Description

Despite increasing evidence for a significant neurobiological basis to aggression, biological interventions have been largely side-stepped, despite the fact that violence is a global public health problem. An important need is to develop socially acceptable ways of bettering brain functioning to reduce adolescent behavior problems, a critical developmental stage for adult violence perpetration and mental health problems. This is the primary health challenge that this proposal aims to tackle. Our pilot data documents that omega-3, a long-chain fatty acid which is critical for brain structure and function, reduces behavior problems in children and adolescents six months after the end of supplementation. If it can further document support and extension of the pilot findings with dual supplementation to both parent and adolescent, and if the investigators can begin to identify the mechanisms of action underlying change, this can provide a new vista on biological interventions for adolescent externalizing problems that predispose to violence. The overarching, long-term goals are to develop a non-invasive biological approach to prevention of youth aggression, and ultimately adult violence.

The specific aims of this 2 x 2 randomized, double-blind, stratified, placebo-controlled trial of omega-3 supplementation to adolescents and caregivers are: (1) to investigate whether a nutritional intervention to adolescents and their parents can reduce externalizing behavior problems; (2) to examine the impact of a dual nutritional intervention to both parents and adolescents on adolescent externalizing behavior problems; (3) to identify mechanisms of action by which omega-3 supplementation impacts externalizing behavior in adolescents. It is expected that omega-3 supplementation will reduce adolescent behavior problems, and that dual supplementation to both the caregiver and adolescent will result in exponential improvements in adolescent behavior. A secondary prediction is that improvements in neurocognitive functioning will partially account for any behavioral improvements observed. Effects on scholastic ability are also explored.

The paradigm-shift that could influence clinical practice is the use of a biological intervention that is not solely focused on the adolescent, but which is also applied to the primary caregiver. To the investigators' knowledge, such dual supplementation has never been examined. From an epidemiological standpoint, if this dual intervention approach could reduce even modestly the overall level of aggressive and antisocial behavior in the community at large, there is the promise of enhancing child health and development with a clinical paradigm novel in the biological study of behavior problems. The study's significance extends beyond adolescent behavior problems, which predispose not just to later adult violence, but also a wide array of adult psychiatric disorders. These adult outcomes result in an enormous societal burden in terms of economic costs, reduced occupational functioning, social functioning, and quality of life for both victims and perpetrators, a burden which could be significantly ameliorated if the pilot findings are supported.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
800 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
2 x 2 randomized, double-blind, stratified, placebo-controlled trial2 x 2 randomized, double-blind, stratified, placebo-controlled trial
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description:
The study is double-blind. Neither the participant nor the caregiver not the outcomes Assessor will know which group the participant is assigned to. The local PI in Mauritius (Tashneem Mahoomed, National Director) will also be blind to treatment condition. Only the PI in Philadelphia will have knowledge of treatment assignment, and he has no contact with participants in Mauritius.
Primary Purpose:
Treatment
Official Title:
Omega-3 Supplementation to Both Parent and Adolescent to Reduce Behavior Problems
Actual Study Start Date :
Mar 5, 2018
Anticipated Primary Completion Date :
Jul 31, 2023
Anticipated Study Completion Date :
Jul 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Both Parent and child

Smartfish Omega Both parent and child receive Omega-3 drink

Dietary Supplement: Smartfish Omega
Fruit juice drink containing Omega-3: the experimental condition

Experimental: Parent Only

Smartfish Omega Only the parent receives Omega-3 drink, child receives Placebo.

Dietary Supplement: Smartfish Omega
Fruit juice drink containing Omega-3: the experimental condition

Dietary Supplement: Smartfish Fruit Juice Only
this is a fruit juice drink with no omega-3 added. it is the placebo condition

Experimental: Child Only

Smartfish Omega Only the child receives Omega-3 drink, the parent receives placebo

Dietary Supplement: Smartfish Omega
Fruit juice drink containing Omega-3: the experimental condition

Dietary Supplement: Smartfish Fruit Juice Only
this is a fruit juice drink with no omega-3 added. it is the placebo condition

Placebo Comparator: Neither

Smartfish Fruit Juice Only Neither parent nor child receives omega-3; both receive placebo (fruit juice).

Dietary Supplement: Smartfish Fruit Juice Only
this is a fruit juice drink with no omega-3 added. it is the placebo condition

Outcome Measures

Primary Outcome Measures

  1. Change in behavior problems [0, 6, 12, 18 months]

    Behavior problems are assessed on a battery of measures with standardized units from parent and child reports. . Aggressive behavior, rule-breaking behavior, and attention problems will be assessed using the Youth Self-Report (YSR; Achenbach & Rescorla, 2001). The fourth scale is the 10-item version of the Inventory of Callous-Unemotional Traits (ICU; Ray et al., 2016). The final two scales are the Reactive and Proactive Aggression scales of the Reactive and Proactive Aggression Questionnaire (Raine et al. 2006). To reduce variables to a more reliable and all-encompassing construct of antisocial behavior, and to avoid Type 1 error, a principal components analysis was conducted on these six measures. Factor scores will be saved using the regression method, with higher scores indicating higher child antisocial behavior. Factor scores over time will be assessed.

Secondary Outcome Measures

  1. Change in neurocognitive functioning [0,6,12,18 months]

    assessed from a neuropsychological test battery: standardized units. The Digit Forward, Digit Backward, Coding, and Arithmetic, Pairing, and Free Recall tests will be administered using the Wechsler Intelligence Scale for Children (WISC-III; Wechsler, 1991), together with the Trails A and Trails B tests.Factor scores will be saved using the regression method, with higher scores indicating higher cold EFs. Chganges in factor scores over time will be evaluated.

  2. Change in substance use. [0, 6,12,18 months]

    smoking, alcohol, marijuana: standardized units. These will be assessed based on the Achenbach Adult Self-Report. Change over time will be evaluated.

Eligibility Criteria

Criteria

Ages Eligible for Study:
11 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • adolescents between Age 11 and 18

  • willing to participate in a randomized control trial

  • parent participated in prior Mauritius Child Health Project

Exclusion Criteria:
  • Allergy to fish or fish products

  • Intellectual disability

  • Use of fish oil supplementations in the past 6 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Joint Child Health Project Quatre Bornes Mauritius

Sponsors and Collaborators

  • Joint Child Health Project, Mauritius
  • University of Pennsylvania

Investigators

  • Principal Investigator: Adrian Raine, D.Phil., University of Pennsylvania
  • Study Director: Tashneem Mahoomed, BSc, Joint Child Health Project

Study Documents (Full-Text)

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Joint Child Health Project, Mauritius
ClinicalTrials.gov Identifier:
NCT05893550
Other Study ID Numbers:
  • JCHP-2
First Posted:
Jun 8, 2023
Last Update Posted:
Jun 8, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 8, 2023